ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,494Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 780

$888K Total Retail Price of All Prescriptions

Rank: 95 out of 780

808 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 808 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 808 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 845 613 S3 1 1
LEVOTHYROXINE SODIUM 653 504 2 5
SIMVASTATIN 622 483 3 2
OMEPRAZOLE 570 353 4 3
AMLODIPINE BESYLATE 545 368 5 4
ZOLPIDEM TARTRATE 461 323 6 17
LISINOPRIL 442 341 7 6
METFORMIN HCL 437 284 8 8
FUROSEMIDE 337 255 9 7
TRAMADOL HCL 274 220 10 15
ATORVASTATIN CALCIUM 268 190 11 12
GABAPENTIN 224 174 12 13
AMLODIPINE BESYLATE-BENAZEPRIL 224 166 12 50
NEXIUM 220 132 14 22
MELOXICAM 201 142 15 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 134 16 26
CLONIDINE HCL 178 120 17 28
HYDROCHLOROTHIAZIDE 178 148 17 10
TAMSULOSIN HCL 160 99 19 36
PRAVASTATIN SODIUM 158 115 20 9
CRESTOR 156 94 21 32
LOVASTATIN 156 125 21 47
CARVEDILOL 149 123 23 14
CYCLOBENZAPRINE HCL 147 94 R 24 42
CITALOPRAM HBR 146 124 25 23
POTASSIUM CHLORIDE 145 125 26 11
ATENOLOL 145 74 26 21
WARFARIN SODIUM 145 96 26 24
PROMETHAZINE HCL 144 50 R 29 66
METOPROLOL TARTRATE 134 113 30 19
DONEPEZIL HCL 133 133 31 31
KLOR-CON 10 132 99 32 90
KLOR-CON M20 131 123 33 57
SERTRALINE HCL 130 84 34 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 125 57 35 88
METOPROLOL SUCCINATE 120 112 36 20
PANTOPRAZOLE SODIUM 119 89 37 25
ESCITALOPRAM OXALATE 118 79 38 61
ADVAIR DISKUS 114 46 39 68
AMITRIPTYLINE HCL 110 53 R 40 48
TRIAMTERENE-HCTZ 104 97 41 37
DIOVAN 102 81 42 55
MEGESTROL ACETATE 100 99 R 43 161
ALENDRONATE SODIUM 99 54 44 44
TRAZODONE HCL 97 43 45 35
LOSARTAN POTASSIUM 95 93 46 18
CLOPIDOGREL 93 83 47 34
FLUCONAZOLE 93 42 47 111
LOSARTAN-HYDROCHLOROTHIAZIDE 89 58 49 33
ESTRADIOL 89 36 R 49 122
SYNTHROID 87 54 51 77
FLUTICASONE PROPIONATE 85 28 52 41
HYDRALAZINE HCL 82 73 53 54
DIOVAN HCT 82 61 53 75
AZITHROMYCIN 77 52 55 38
SPIRIVA 76 66 56 72
FLUOXETINE HCL 74 42 57 65
CARISOPRODOL 73 25 R 58 67
LYRICA 72 49 59 52
POLYETHYLENE GLYCOL 3350 71 30 60 79
TRICOR 70 18 61 152
MIRTAZAPINE 69 51 62 58
MECLIZINE HCL 69 54 62 83
PREDNISONE 68 30 64 40
CIPROFLOXACIN HCL 67 50 65 49
SINGULAIR 66 29 66 73
CYMBALTA 65 35 67 51
PAROXETINE HCL 65 39 67 69
NAMENDA 62 62 69 46
PROAIR HFA 61 38 70 62
PREMARIN 61 50 R 70 110
ZETIA 61 32 70 94
ISOSORBIDE MONONITRATE ER 60 59 73 60
PLAVIX 59 50 74 45
IBUPROFEN 59 41 74 93
CELEBREX 55 33 76 89
AMPHETAMINE SALT COMBO 55 23 S2 76 201
PROPRANOLOL HCL 54 27 78 133
VENTOLIN HFA 52 34 79 91
EXFORGE 51 44 80 196
TOPIRAMATE 50 15 81 145
GLIPIZIDE 50 32 81 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.